WebNGS for Infectious Disease Surveillance. Genomic analysis with NGS provides high-resolution information to distinguish pathogen strains that differ by as little as one single-nucleotide polymorphism (SNP). It also allows identification of both novel and known infectious agents. NGS technology delivers rapid results and high-quality data to help
See Also: Tech Support Preview / Show details
WebJun 24, 2022 · Illumina Acquires IDbyDNA. June 24, 2022 Illumina has acquired IDbyDNA, a company developing metagenomic technology for infectious disease testing and …
See Also: Tech Support Preview / Show details
WebNov 2, 2015 · 1. IDbyDNA. @idbydnainc. ·. Apr 27. IDbyDNA announces software update to their #Explify ®* platform, improving assay analytical performance and software user experience. Check out this news article for more details rb.gy/sw153o *For Research Only. Not for use in diagnostic procedures. 2.
See Also: Phone Number Preview / Show details
WebJun 24, 2022 · Diagnostics Disease Areas Resources Genomics: Clinical Implementation Breadcrumb Illumina Acquires IDbyDNA Save for later NEW YORK – Illumina has acquired IDbyDNA, a company developing metagenomic technology for infectious disease testing and pathogen surveillance, GenomeWeb has learned today.
See Also: Tech Support Preview / Show details
WebCompany profile page for IDbyDNA Inc including stock price, company news, press releases, executives, board members, and contact information
See Also: Contact Support Preview / Show details
WebSep 1, 2020 · Closely-held clinical metagenomics company, IDbyDNA, is commercializing its Explify platform with the goal of replacing traditional pathogen detection with a data-driven approach. “Our vision is to deploy our metagenomics operating system in hospitals and laboratories around the world, putting the technology closer to patients to collectively …
See Also: Tech Support Preview / Show details